Peptide record

TPDB91241

maximin1 Antibacterial Anticancer Antifungal Antioxidant Antiparasitic Antiviral Hemolysis Toxicity modified_plain modified
27 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB91241
maximin1
Antibacterial Anticancer Antifungal Antioxidant Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides Functional / health-promoting peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF pep-lab AFP-GFuse Antifungipept CAFPdb dbAMP 3.0 AI4AVP AVPpred-BWR DRAVP 2.0 APD_complete APD_hemolytic Hemolytic2
modified_plain
Yes
A 27-aa modified multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
C-terminal: Amidation
Sequence
GIGTKILGGVKTALKGALKELASTYAN-NH2
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
27 reviewed residue count
Amidation Activity
L Activity
Linear Activity
Free Activity
Antimicrobial Activity
Bombina maxima Activity
Evidence Records 4 records
Evidence 1 Activity

Activity

IC50
IC50=15.3 µg/ml
Anticancer
15.3 µg/mL

Target

Leukemia Cancer
C8166
Blood

Assay & Model

MTT/MTS assay
48-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2001

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation. dbAMP 3.0 classified as Anticancer under the disease-associated peptide function classes.
Evidence 2 Activity

Activity

IC50
IC50=24.3 µg/ml
Anticancer
24.3 µg/mL

Target

Leukemia Cancer
MOLT-4
Blood

Assay & Model

MTT/MTS assay
48-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2001
Evidence 3 Activity

Activity

IC50
IC50=20.5 µg/ml
Anticancer
20.5 µg/mL

Target

Bladder Cancer
BIU-87
Bladder

Assay & Model

MTT/MTS assay
48-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2001
Evidence 4 Activity

Activity

IC50
IC50 =35.4 µg/ml
Anticancer
35.4 µg/mL

Target

Bladder Cancer
T-24
Bladder

Assay & Model

MTT/MTS assay
48-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2001